Management of Refractory/Relapsed Acute Leukemia with Heart Limitation by Anthracycline-free Chemotherapy Regimens in Pediatric Patients: New Hypothesis and New Approach
Background: Anthracycline therapy for acute leukemia may be associated with significant morbidity and mortality in children or elderly patients that have a degree of heart failure. Patients with prior anthracycline exposure, those with pre-existing heart disease, or who have received the total anthr...
Main Authors: | Babak Abdolkarimi, Soheila Zareifar, Mehran Karimi, Pouria Salajegheh |
---|---|
Format: | Article |
Language: | English |
Published: |
Shiraz University of Medical Sciences
2018-04-01
|
Series: | Middle East Journal of Cancer |
Subjects: | |
Online Access: | http://mejc.sums.ac.ir/index.php/mejc/article/view/594 |
Similar Items
-
The Outcome Of Antracycline-Based Combination Chemotherapy In Metastatic Breast Cancer As A First-Line Treatment
by: Ahmet Dirier, et al.
Published: (2003-03-01) -
PREVENTION OF ANTRACYCLIN ANTIBIOTIC DOXORUBICIN СARDIOTOXICITY: A ROLE OF ACE-INHIBITOR PERINDOPRIL
by: E. V. Pravdivtseva, et al.
Published: (2014-07-01) -
PREVENTION OF ANTRACYCLIN ANTIBIOTIC DOXORUBICIN СARDIOTOXICITY: A ROLE OF ACE-INHIBITOR PERINDOPRIL
by: E. V. Pravdivtseva, et al.
Published: (2014-07-01) -
Sequential vs concurrent adjuvant chemotherapy of anthracycline and taxane for operable breast cancer
by: Wanjing Chen, et al.
Published: (2021-02-01) -
The mortality and response rate after FLANG regimen in patients with refractory/relapsed acute leukemia
by: Vali A Mehrzad, et al.
Published: (2012-01-01)